Safety And Efficacy Of Xalatan Delivered Using Either A Conventional Dropper Bottle or A Delivery Device
Clinical trial NCT00283764 · WITHDRAWN
Trial details
- NCT number
- NCT00283764
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.